DB12189

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2020
gptkbp:ATCCode J05AB16
gptkbp:bioavailability Low (IV only)
gptkbp:brand gptkb:Veklury
gptkbp:CASNumber 1809249-37-3
gptkbp:contraindication hypersensitivity to remdesivir
gptkbp:developer gptkb:Gilead_Sciences
gptkbp:drugClass antiviral drug
antiviral
gptkbp:eliminationHalfLife 1 hour (remdesivir), 25 hours (GS-441524)
gptkbp:excretion Renal
gptkbp:form solution for injection
lyophilized powder for injection
gptkbp:hasBoxedWarning nan
gptkbp:hasFirstApprovalCountry gptkb:United_States
gptkbp:hasFirstApprovalDate 2020-10-22
gptkbp:hasInChIKey RWWYLEGWBNMMLJ-YSOARWBDSA-N
gptkbp:hasMolecularFormula C27H35N6O8P
gptkbp:hasPatentHolder gptkb:Gilead_Sciences
gptkbp:hasPharmacokinetics rapidly converted to active nucleoside analog GS-441524
gptkbp:hasResearchUse investigational for other viral infections
gptkbp:hasSMILES CC(C)[C@@H](NC(=O)[C@@H](COP(=O)(OCC1=CN=CN1)OCC2=CN(C3=NC=NC(=C23)N)C)O)C(=O)N
gptkbp:hasStorageCondition Refrigerated
gptkbp:hasUNII 53J0A36V2L
https://www.w3.org/2000/01/rdf-schema#label DB12189
gptkbp:indication gptkb:COVID-19
gptkb:Ebola_virus_infection_(investigational)
gptkbp:legalStatus patented
Prescription only
gptkbp:mechanismOfAction RNA-dependent RNA polymerase inhibitor
gptkbp:metabolism Hepatic
gptkbp:molecularWeight 602.6 g/mol
gptkbp:name gptkb:Remdesivir
gptkbp:pregnancyCategory Not assigned
gptkbp:PubChem_CID gptkb:DB12189
121304016
CHEMBL2016761
D11960
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect nausea
elevated liver enzymes
hypersensitivity
gptkbp:status FDA approved
gptkbp:structureType prodrug
gptkbp:synonym gptkb:GS-5734
gptkbp:target RNA-dependent RNA polymerase
gptkbp:therapeuticArea gptkb:disease
gptkbp:WHOModelListOfEssentialMedicines not listed
gptkbp:bfsParent gptkb:151096-09-2
gptkbp:bfsLayer 6